247 related articles for article (PubMed ID: 22222170)
1. Treatment with simvastatin inhibits the formation of abdominal aortic aneurysms in rabbits.
Mastoraki ST; Toumpoulis IK; Anagnostopoulos CE; Tiniakos D; Papalois A; Chamogeorgakis TP; Angouras DC; Rokkas CK
Ann Vasc Surg; 2012 Feb; 26(2):250-8. PubMed ID: 22222170
[TBL] [Abstract][Full Text] [Related]
2. A novel rat model of abdominal aortic aneurysm using a combination of intraluminal elastase infusion and extraluminal calcium chloride exposure.
Tanaka A; Hasegawa T; Chen Z; Okita Y; Okada K
J Vasc Surg; 2009 Dec; 50(6):1423-32. PubMed ID: 19958989
[TBL] [Abstract][Full Text] [Related]
3. Simvastatin suppresses experimental aortic aneurysm expansion.
Kalyanasundaram A; Elmore JR; Manazer JR; Golden A; Franklin DP; Galt SW; Zakhary EM; Carey DJ
J Vasc Surg; 2006 Jan; 43(1):117-24. PubMed ID: 16414398
[TBL] [Abstract][Full Text] [Related]
4. Effects of tissue inhibitor of metalloproteinase 2 deficiency on aneurysm formation.
Xiong W; Knispel R; Mactaggart J; Baxter BT
J Vasc Surg; 2006 Nov; 44(5):1061-6. PubMed ID: 17098543
[TBL] [Abstract][Full Text] [Related]
5. The Influence of Simvastatin on NGAL, Matrix Metalloproteinases and Their Tissue Inhibitors in Human Intraluminal Thrombus and Abdominal Aortic Aneurysm Tissue.
Piechota-Polanczyk A; Demyanets S; Mittlboeck M; Hofmann M; Domenig CM; Neumayer C; Wojta J; Klinger M; Nanobachvili J; Huk I
Eur J Vasc Endovasc Surg; 2015 May; 49(5):549-55. PubMed ID: 25800096
[TBL] [Abstract][Full Text] [Related]
6. A nonintrinsic regional basis for increased infrarenal aortic MMP-9 expression and activity.
Ailawadi G; Knipp BS; Lu G; Roelofs KJ; Ford JW; Hannawa KK; Bishop K; Thanaporn P; Henke PK; Stanley JC; Upchurch GR
J Vasc Surg; 2003 May; 37(5):1059-66. PubMed ID: 12756355
[TBL] [Abstract][Full Text] [Related]
7. Free-radical scavenger edaravone inhibits both formation and development of abdominal aortic aneurysm in rats.
Morimoto K; Hasegawa T; Tanaka A; Wulan B; Yu J; Morimoto N; Okita Y; Okada K
J Vasc Surg; 2012 Jun; 55(6):1749-58. PubMed ID: 22341578
[TBL] [Abstract][Full Text] [Related]
8. Suppression of abdominal aortic aneurysm formation by inhibition of prolyl hydroxylase domain protein through attenuation of inflammation and extracellular matrix disruption.
Watanabe A; Ichiki T; Sankoda C; Takahara Y; Ikeda J; Inoue E; Tokunou T; Kitamoto S; Sunagawa K
Clin Sci (Lond); 2014 May; 126(9):671-8. PubMed ID: 24256203
[TBL] [Abstract][Full Text] [Related]
9. Activation of transglutaminase type 2 for aortic wall protection in a rat abdominal aortic aneurysm formation.
Munezane T; Hasegawa T; Suritala ; Tanaka A; Okada K; Okita Y
J Vasc Surg; 2010 Oct; 52(4):967-74. PubMed ID: 20615646
[TBL] [Abstract][Full Text] [Related]
10. Exploration of the mechanisms by which 3,4-benzopyrene promotes angiotensin II-induced abdominal aortic aneurysm formation in mice.
Ji K; Zhang Y; Jiang F; Qian L; Guo H; Hu J; Liao L; Tang J
J Vasc Surg; 2014 Feb; 59(2):492-9. PubMed ID: 23676189
[TBL] [Abstract][Full Text] [Related]
11. Orally administered dipeptidyl peptidase-4 inhibitor (alogliptin) prevents abdominal aortic aneurysm formation through an antioxidant effect in rats.
Bao W; Morimoto K; Hasegawa T; Sasaki N; Yamashita T; Hirata K; Okita Y; Okada K
J Vasc Surg; 2014 Apr; 59(4):1098-108. PubMed ID: 23790558
[TBL] [Abstract][Full Text] [Related]
12. Effect of novel limited-spectrum MMP inhibitor XL784 in abdominal aortic aneurysms.
Ennis T; Jin J; Bartlett S; Arif B; Grapperhaus K; Curci JA
J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):417-26. PubMed ID: 22894883
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase 8 (neutrophil collagenase) in the pathogenesis of abdominal aortic aneurysm.
Wilson WR; Schwalbe EC; Jones JL; Bell PR; Thompson MM
Br J Surg; 2005 Jul; 92(7):828-33. PubMed ID: 15918165
[TBL] [Abstract][Full Text] [Related]
14. Interference of doxycycline pretreatment in a model of abdominal aortic aneurysms.
Mata KM; Tefé-Silva C; Floriano EM; Fernandes CR; Rizzi E; Gerlach RF; Mazzuca MQ; Ramos SG
Cardiovasc Pathol; 2015; 24(2):110-20. PubMed ID: 25466491
[TBL] [Abstract][Full Text] [Related]
15. Elastin stabilization for treatment of abdominal aortic aneurysms.
Isenburg JC; Simionescu DT; Starcher BC; Vyavahare NR
Circulation; 2007 Apr; 115(13):1729-37. PubMed ID: 17372168
[TBL] [Abstract][Full Text] [Related]
16. A randomized placebo controlled trial of the effect of preoperative statin use on matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in areas of low and peak wall stress in patients undergoing elective open repair of abdominal aortic aneurysm.
Rahman MN; Khan JA; Mazari FA; Mockford K; McCollum PT; Chetter IC
Ann Vasc Surg; 2011 Jan; 25(1):32-8. PubMed ID: 20889295
[TBL] [Abstract][Full Text] [Related]
17. Effect of hyperbaric oxygen treatment in a rat model of abdominal aortic aneurysm.
Yalcin M; Yiğiner O; Eroğlu M; Sehirli O; Berber U; Ozçelik F; Sener G
Undersea Hyperb Med; 2014; 41(1):9-15. PubMed ID: 24649712
[TBL] [Abstract][Full Text] [Related]
18. Controlled release of ascorbic acid from gelatin hydrogel attenuates abdominal aortic aneurysm formation in rat experimental abdominal aortic aneurysm model.
Tanaka A; Hasegawa T; Morimoto K; Bao W; Yu J; Okita Y; Tabata Y; Okada K
J Vasc Surg; 2014 Sep; 60(3):749-58. PubMed ID: 24011462
[TBL] [Abstract][Full Text] [Related]
19. Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms.
Nishimura K; Ikebuchi M; Kanaoka Y; Ohgi S; Ueta E; Nanba E; Ito H
Int Angiol; 2003 Sep; 22(3):229-38. PubMed ID: 14612849
[TBL] [Abstract][Full Text] [Related]
20. [Effects of Tongxinluo and Simvastatin on the stabilization of vulnerable atherosclerotic plaques of aorta in aortic atherosclerosis and molecular mechanism thereof: a comparative study with rabbits].
Li Z; Yang YJ; Qin XW; Ruan YM; Chen X; Meng L; Zhang HD
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3146-50. PubMed ID: 17313769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
